Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Macri

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|September 1, 1977
Prolactin and human placental lactogen changes in maternal serum and amniotic fluid in midtrimester induced abortionsR R Weiss, A G Frantz, J N Macri, et al.
JAMA|May 16, 1977
Progress in screening for neural tube defectsJ N Macri, R R Weiss, N B Schell, et al.
American Journal of Human Genetics|February 1, 1989
Variability in MSAFP predicted rates of Down syndromeJ N Macri, D A Krantz, E J Cook, et al.
Prenatal Diagnosis|June 1, 1995
Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screeningE Berry, D A Aitken, J A Crossley, et al.
Prenatal Diagnosis|September 1, 1996
Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnanciesC H Laundon, K Spencer, J N Macri, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1997
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimestersE Berry, D A Aitken, J A Crossley, et al.
Pediatric Research|March 1, 1978
Second trimester amniotic fluid protein values from normal, neural tube defect, and fetal demise pregnancies after exclusion of material blood contaminated by testing for pregnancy-associated macroglobulinJ E Haddow, F S Cowchock, J N Macri, et al.
Lancet (London, England)|October 11, 1975
Letter: Maternal serum alpha-fetoprotein and prospective screeningJ N Macri, R R Weiss, N A Starkovsky, et al.
American Journal of Human Genetics|March 1, 1990
Maternal serum alpha-fetoprotein (MSAFP) patient-specific risk reporting: its use and misuseJ N Macri, R V Kasturi, D A Krantz, et al.
American Journal of Obstetrics and Gynecology|February 1, 1996
Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndromeJ N Macri, R W Anderson, D A Krantz, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|September 1, 1977
Prolactin and human placental lactogen changes in maternal serum and amniotic fluid in midtrimester induced abortionsR R Weiss, A G Frantz, J N Macri, et al.
JAMA|May 16, 1977
Progress in screening for neural tube defectsJ N Macri, R R Weiss, N B Schell, et al.
American Journal of Human Genetics|February 1, 1989
Variability in MSAFP predicted rates of Down syndromeJ N Macri, D A Krantz, E J Cook, et al.
Prenatal Diagnosis|June 1, 1995
Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screeningE Berry, D A Aitken, J A Crossley, et al.
Prenatal Diagnosis|September 1, 1996
Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnanciesC H Laundon, K Spencer, J N Macri, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1997
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimestersE Berry, D A Aitken, J A Crossley, et al.
Pediatric Research|March 1, 1978
Second trimester amniotic fluid protein values from normal, neural tube defect, and fetal demise pregnancies after exclusion of material blood contaminated by testing for pregnancy-associated macroglobulinJ E Haddow, F S Cowchock, J N Macri, et al.
Lancet (London, England)|October 11, 1975
Letter: Maternal serum alpha-fetoprotein and prospective screeningJ N Macri, R R Weiss, N A Starkovsky, et al.
American Journal of Human Genetics|March 1, 1990
Maternal serum alpha-fetoprotein (MSAFP) patient-specific risk reporting: its use and misuseJ N Macri, R V Kasturi, D A Krantz, et al.
American Journal of Obstetrics and Gynecology|February 1, 1996
Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndromeJ N Macri, R W Anderson, D A Krantz, et al.
Pageof 8